NasdaqGS - Delayed Quote USD

Legend Biotech Corporation (LEGN)

45.30 +0.88 (+1.98%)
At close: April 26 at 4:00 PM EDT
45.30 0.00 (0.00%)
After hours: April 26 at 5:10 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for LEGN

Recent News: LEGN

View More
CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma

CARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Business Wire 5 days ago
Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results

Legend Biotech to Host Investor Conference Call on First Quarter 2024 Results
Business Wire 16 days ago
FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma

FDA Expands J&J's (JNJ) Carvykti Label in Multiple Myeloma
Zacks 19 days ago
Why Legend Biotech (LEGN) Stock Might be a Great Pick

Why Legend Biotech (LEGN) Stock Might be a Great Pick
Zacks 19 days ago
Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma

Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma
Business Wire 22 days ago
Should You Continue to Hold Legend Biotech Corporation (LEGN)?

Should You Continue to Hold Legend Biotech Corporation (LEGN)?
Insider Monkey 24 days ago
Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4

Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4
Insider Monkey 29 days ago
Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report

Legend Biotech Announces Publication of Inaugural Environmental, Social and Governance (ESG) Report
Business Wire last month
30 Biggest Biotechnology Companies in the World

30 Biggest Biotechnology Companies in the World
Insider Monkey last month
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma

CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Business Wire last month
Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript

Legend Biotech Corporation (NASDAQ:LEGN) Q4 2023 Earnings Call Transcript
Insider Monkey last month
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys

The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
Zacks last month
View More

Related Tickers

BGNE BeiGene, Ltd.
153.58
+3.38%
 
BPMC Blueprint Medicines Corporation
93.00
+2.50%
 
GMAB Genmab A/S
28.15
+2.51%
 
APLS Apellis Pharmaceuticals, Inc.
49.86
+4.03%
 
ALNY Alnylam Pharmaceuticals, Inc.
143.31
-0.28%
 
ALXO ALX Oncology Holdings Inc.
16.86
-0.06%
 
ASND Ascendis Pharma A/S
135.90
-0.75%
 
APGE Apogee Therapeutics, Inc.
47.13
+2.77%
 
KRYS Krystal Biotech, Inc.
156.88
+0.77%
 
CYTK Cytokinetics, Incorporated
65.34
+0.83%